Cargando…
Strong Neck Accumulation of (131)I Is a Predictor of Incomplete Low-Dose Radioiodine Remnant Ablation Using Recombinant Human Thyroid-Stimulating Hormone
The purpose of this study was to identify the factors that predict incomplete low-dose radioiodine remnant ablation (RRA) with recombinant human thyroid-stimulating hormone (rhTSH) and to report the adverse events associated with this treatment. Between 2012 and 2014, 43 consecutive patients with th...
Autores principales: | Enomoto, Keisuke, Sakata, Yoshiharu, Izumi, Kazuyuki, Takenaka, Yukinori, Nagai, Miki, Takeda, Kazuya, Enomoto, Yukie, Uno, Atsuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616877/ https://www.ncbi.nlm.nih.gov/pubmed/26426611 http://dx.doi.org/10.1097/MD.0000000000001490 |
Ejemplares similares
-
Assessment of three different radioiodine doses for ablation therapy of thyroid remnants: Efficiency, complications and patient comfort
por: Soyluoglu, Selin, et al.
Publicado: (2023) -
Recombinant human TSH stimulated thyroglobulin levels at remnant ablation predict structural incomplete response to treatment in patients with differentiated thyroid cancer
por: Ha, Jeonghoon, et al.
Publicado: (2017) -
Graves disease following radioiodine therapy for toxic adenoma: Clinical case report
por: Shen, Guohua, et al.
Publicado: (2017) -
Time course of Graves’ orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancer
por: Louvet, Camille, et al.
Publicado: (2016) -
Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer
por: Upadhyaya, Arun, et al.
Publicado: (2017)